U.S. IPOs continued to make a strong showing this week, with 11 deals raising an aggregate of $ 1.6 billion in proceeds. It was the busiest week since the week of November 5, 2007, which saw 13 pricings. Performance was mixed, with an average total return of 7%; seven of the 11 deals were trading below their offer price by the end of the week. Momentum is expected to continue, with eight companies setting terms and nine U.S. IPOs scheduled to price next week. Three companies submitted their initial filings with the SEC, adding to our active IPO pipeline, which now stands at 104 companies planning to raise an aggregate of $ 32.1 billion.
|IPO pricings (week of July 22, 2013)|
|Company (Ticker)||Business||Deal Size ($ mm)||Price vs. Midpoint||Return|
|Agios Pharmaceuticals (AGIO)||Cancer biotech||$ 106||20%||58%|
|Cellular Dynamics (ICEL)||Human cell company||$ 46||-8%||-16%|
|Conatus Pharmaceuticals (CNAT)|